Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Medicus Pharma Ltd (NASDAQ: MDCX) closed at $2.55 down -29.85% from its previous closing price of $3.63. In other words, the price has decreased by -$29.85 from its previous closing price. On the day, 1.96 million shares were traded.
Ratios:
For a deeper understanding of Medicus Pharma Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.08.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 20 ’25 when VELOCITY FUND PARTNERS, LP sold 75,000 shares for $7.72 per share. The transaction valued at 578,940 led to the insider holds 3,248,741 shares of the business.
VELOCITY FUND PARTNERS, LP bought 118,000 shares of MDCX for $23,067,500 on May 20 ’25.
Stock Price History:
Over the past 52 weeks, MDCX has reached a high of $8.94, while it has fallen to a 52-week low of $1.80. The 50-Day Moving Average of the stock is -42.13%, while the 200-Day Moving Average is calculated to be -27.92%.
Shares Statistics:
A total of 13.42M shares are outstanding, with a floating share count of 2.34M. Insiders hold about 80.22% of the company’s shares, while institutions hold 25.73% stake in the company.
Earnings Estimates
Currently, 2 analysts are dedicated to thoroughly evaluating and rating the performance of Medicus Pharma Ltd (MDCX) in the stock market.The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.12 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$0.55 and -$1.46 for the fiscal current year, implying an average EPS of -$1.0. EPS for the following year is -$0.77, with 2.0 analysts recommending between -$0.43 and -$1.12.
